Fact CheckerSign in

NCT06381284Completed

Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment

Source: ClinicalTrials.gov · Last updated 25 Mar 2025

Brief summary (registry, in English)

This is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The main study objective is to evaluate the feasibility of a social media recruitment campaign tied to a participant reported symptom survey and self-administered physical assessment tool to influence undiagnosed participants to seek care for suspected Myasthenia Gravis (MG).

Status (registry)
Completed
Study type
Observational
Enrollment
215 (actual)
First submitted
18 Apr 2024
Start date
28 Mar 2024
Primary completion date
3 Mar 2025
Lead sponsor
ZS Associates
NCT number
NCT06381284

What you commit to

  • Study type: Observational
  • Participants enrolled: 215
  • From 28 Mar 2024 to the primary completion date, 3 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Have speech impairment, eye/arm/leg weakness due to diagnosed brain cancer, or stroke

Other

  • Live in an overseas territory of the United States
  • Inability or unwillingness to provide written informed consent
  • Diagnosed myasthenia gravis
  • Diagnosed multiple sclerosis

Who the study is looking for

  • Reside within the 50 states of the United States at the time of enrollment
  • Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state
  • Active email account
  • Fluency in English (spoken / written), as demonstrated by the ability to read and sign the Informed Consent Form

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
ZS Associates
Coordinator of this site? Confirm its status
EvanstonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.